From: Metabolic syndrome components and acute pancreatitis: a case–control study in China
Non-AP patients (n = 356) | AP patients (n = 349) | OR (95% CI) | p | |
---|---|---|---|---|
Smoking, n (%) | 62 (17.4) | 125 (35.8) | 2.441 (1.865–5.172) | < 0.001 |
Alcohol drinking, n (%) | 53 (14.9) | 101 (28.9) | 1.777 (1.060–2.977) | 0.029 |
Biliary stone, n (%) | 8 (2.3) | 101 (28.9) | 28.995 (13.253–63.435) | < 0.001 |
Hepatitis B, n (%) | 17 (4.8) | 7 (2.0) | 0.439 (0.145–1.327) | 0.145 |
Obesity, n (%) | 120 (33.7) | 157 (45.0) | 1.258 (0.854–1.855) | 0.246 |
TC ≥ 220 mg/dL, n (%) | 61 (17.1) | 106 (30.4) | 1.992 (1.246–3.183) | 0.004 |
TG ≥ 150 mg/dL, n (%) | 97 (27.2) | 162 (46.4) | 2.134 (1.403–3.245) | < 0.001 |
HDL ≥ 40 mg/dL (M) or ≥ 50 mg/dL (F), n (%) | 183 (51.4) | 133 (38.1) | 0.784 (0.522–1.176) | 0.240 |
Apo A ≥ 1 g/L, n (%) | 321 (90.2) | 230 (65.9) | 0.270 (0.163–0.447) | < 0.001 |
Hyperglycaemia, n (%) | 37 (10.4) | 93 (26.7) | 2.261 (1.367–3.742) | 0.001 |
Hypertension, n (%) | 129 (36.2) | 159 (45.6) | 1.189 (0.817–1.732) | 0.366 |